Board of directors;Adjunct Professor of Yale University; Vice President of West Lake University

Tian Xu is a Founder and Chair of Drug Farm. He is Chair Professor of Genetics and Vice President of Westlake University and Adjunct Professor of Genetics at Yale University. He was an endowed Professor at Yale Medical School and an Investigator of the Howard Hughes Medical Institute for more than two decades before joining Westlake. He served as President of the Chinese Biological Investigators Society and Chair of the Scientific Advisory Board for the Rothberg Institute for Childhood Diseases. The major thrust of Xu’s research effort lies in developing and utilizing novel genetic approaches to understand development and disease. The systematic functional genetics methods that he developed for Drosophila, mice and human cells have been used by the research community throughout the world. In recent years, Dr. Xu explores artificial intelligence and intelligence in research and translation.

Bachelor of Nanjing University, Ph.D. of Cornell University, Postdoctoral of Rockefeller University

Associate Professor of the University of Chicago, the focus of research is the biology of skin stem cells and skin diseases.

Bachelor of Sichuan University, Ph.D. of Iowa State University, Poor Postdoctoral University of California, Berkeley

Yi Jin has more than 20 years of academic research and enterprise research and development experience, including the University of California, Berkeley, Bayer, Kingsley and other internationally renowned institutes, large pharmaceutical companies and CROs. She focuses on tumor immunity, autoimmune, single-gene genetic diseases, etc., and has rich early research and preclinical development experience, including promoting technology platform construction. In terms of academic research, there are dozens of academic papers in academic research in journals such as Cell, Molecular Cell, Development Cell, J. Cell Biol., J. Cell. BioChem. She has rich team management capabilities, including multi-disciplinary and cross-professional team management, especially early R & D, transformation of medicine and preclinical pharmacy, such as CMC, QA/QC, etc.

Bachelor of Changchun University of Traditional Chinese Medicine, Ph.D. in Hengbin City University in Japan

Weili Cong has more than 10 years of experience in the research and development and process development of cell therapy products, including IPS cells, etc. She was an associate researcher at the Shanghai Biochemical Institute

Bachelor of Shanghai Jiaotong University, Ph.D. in Shanghai Jiaotong University

He has experience and quality management experience in Shanghai Rice Blood Products for nearly 10 years; he also has rich team management and coordination capabilities.